Capitalizing on precision medicine : how pharmaceutical firms can shape the future of healthcare
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000cam a22000004b 4500 | ||
| 001 | MAP20180008467 | ||
| 003 | MAP | ||
| 005 | 20180320133022.0 | ||
| 008 | 180319s2017 usa|||| ||| ||eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a931 | ||
| 110 | 2 | $0MAPA20180003615$aDanner, Stephan | |
| 245 | 1 | 0 | $aCapitalizing on precision medicine $b : how pharmaceutical firms can shape the future of healthcare$cStephan Danner, Dr. Thomas Solbach, Mark Ludwig |
| 260 | $bPricewaterhouseCoopers$c2018 | ||
| 520 | $aPrecision medicine holds tremendous potential to remake the healthcare industry. By applying a deeper understanding of diseases with richer patient data and advanced analytics, precision medicine can help physicians tailor medicines to the needs of individual patients, rather than by broader populations, leading to better outcomes at potentially lower costs. | ||
| 650 | 4 | $0MAPA20080606633$aIndustria farmacéutica | |
| 650 | 4 | $0MAPA20160013733$aSalud Digital | |
| 650 | 4 | $0MAPA20080586546$aNuevas tecnologías | |
| 650 | 4 | $0MAPA20090043374$aAtención sociosanitaria | |
| 650 | 4 | $0MAPA20180003806$aMedicina de precisión | |
| 700 | 1 | $0MAPA20180003622$aSolbach, Dr. Thomas | |
| 700 | 1 | $0MAPA20080049416$aLudwig, Mark | |
| 710 | 2 | $0MAPA20080445652$aPricewaterhouseCoopers |